Loading stock…

Bangkok Dusit Medical Services Public Company Limited (BDMS) Stock Verdict & Ratings | Investment Bastion

Stock Verdict·Updated 1d ago

Bangkok Dusit Medical Services Public Company Limited

BDMSMarket cap $8.94BPrice $0.6

Country🇹🇭Thailand

SectorHealthcare

IndustryHealthcare Services

Operates Thailand's largest private hospital network, running over 50 facilities that treat both locals and medical tourists chasing world-class care at a fraction of Western prices. Bangkok's healthcare crown jewel banks on Thailand's booming medical tourism industry.

In Bastion Portfolios?

52W Return-4%Global Market +16%?

01Key Ratings

How does this stock score across Bastion factors?

Growth

Historical Revenue

Rev CAGR (3y)+10%7

Revenue Forecast

Rev CAGR (1y)-5%1

Rev CAGR (3y)+4%3

Rev CAGR (5y)+7%6

Earnings Forecast

EPS Growth Y+1-4%3

EPS Growth Y+2+6%6

EPS Growth Y+3+6%5

Quality

Margins

EBIT Margin17%7

Net Income Margin13%7

Free Cash Flow Margin11%6

Debt

Net Debt/EBITDA0.56

Efficiency

ROE15%6

ROA10%9

Earnings Stability88

GEAR+STRONG72

Overall rating across all five factors

Value

Price Multiples

P/E Ratio (Forward)175

P/E Ratio (Forward 3y)164

P/BV2.95

EV Multiples

EV/EBITDA Fwd115

EV/EBIT Fwd156

Yield

Free Cash Flow Yield4.3%6

Dividend Yieldna–

Momentum

Short term

1 month return-6%4

3 month return-3%6

YTD return+3%5

Mid term

Price vs 52wHigh89%8

1 year return-2%4

Long term

3 year return-22%2

5 year return-1%3

Risk Shield

Price Risk

Beta0.29

Volatility22%9

Free Cash Flow

Free Cash Flow Margin11%6

Free Cash Flow Yield4.3%6

Quality

ROCE15%8

Earnings Stability88

Net Debt/EBITDA0.56

02Growth

Is it actually growing, and how fast?

BDMSBangkok Dusit Medical Services Public Company

Revenue FY25$3.6B

GROWTH RATING↗

WEAK31 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+10%7

Revenue, next 1Y-5%1

Revenue, next 3Y, CAGR+4%3

Revenue, next 5Y, CAGR+7%6

EARNINGS FORECAST▾SCORE

EPS growth, FY26E-4%3

EPS growth, FY27E+6%6

EPS growth, FY28E+6%5

GROWTH ASSESSMENT

STRENGTHS

Revenue grew 10%/yr over the last 3 years, ahead of 60% of companies worldwide.7/10

WATCH

Revenue grew 10%/yr over the last 3 years; forecasts see it cooling to 4%/yr.

Over five years revenue is set to grow 7%/yr, ahead of 50% of companies worldwide.6/10

Earnings are set to grow in step with sales (EPS about 6%/yr vs revenue 4%/yr). One year dips: EPS falls 4% next year.

WEAKNESSES

Growth is the weak spot here, trailing 69% of companies worldwide.

Revenue is set to grow 4%/yr over the next 3 years, behind most of the market.3/10

BOTTOM LINE

Modest Grower

Growth is a weak point here: a business that is slowing. The one thing to watch: forward revenue growth trails the market.

03Price Momentum

Is the market behind it right now?

BDMSBangkok Dusit Medical Services Public Company

Total return Current8.9%

Price return Current−12.7%

MOMENTUM RATING↗

AVERAGE36 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-6%4

3-month return-3%6

YTD return+3%5

MID & LONG-TERM▾SCORE

% of 52-week high89%8

1-year return-2%4

3-year return-22%2

5-year return-1%3

MOMENTUM ASSESSMENT

STRENGTHS

None flagged.

WATCH

It's down 2% over the past year, now 11% below its 52-week high. That is a touch ahead of the market.

Returns sit at the market level over the past month (-6%), over three months (-3%) and so far this year (+3%).

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (-22% over three years and -1.2% over five), behind 70% of the market.

BOTTOM LINE

Mixed Momentum

Horizons disagree or sit near the middle of the pack. Momentum investors may want a clearer trend before sizing up. The one thing to watch: the multi-year record is weak.

04Value

Are you paying a fair price for it?

Stop guessing on Bangkok Dusit Medical Services Public Company Limited. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

BDMSBangkok Dusit Medical Services Public Company

Revenue FY25$3.6B

GROWTH RATING↗

WEAK31 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+10%7

Revenue, next 1Y-5%1

Revenue, next 3Y, CAGR+4%3

Revenue, next 5Y, CAGR+7%6

EARNINGS FORECAST▾SCORE

EPS growth, FY26E-4%3

EPS growth, FY27E+6%6

EPS growth, FY28E+6%5

GROWTH ASSESSMENT

STRENGTHS

Revenue grew 10%/yr over the last 3 years, ahead of 60% of companies worldwide.7/10

WATCH

Revenue grew 10%/yr over the last 3 years; forecasts see it cooling to 4%/yr.

Over five years revenue is set to grow 7%/yr, ahead of 50% of companies worldwide.6/10

Earnings are set to grow in step with sales (EPS about 6%/yr vs revenue 4%/yr). One year dips: EPS falls 4% next year.

WEAKNESSES

Growth is the weak spot here, trailing 69% of companies worldwide.

Revenue is set to grow 4%/yr over the next 3 years, behind most of the market.3/10

BOTTOM LINE

Modest Grower

Growth is a weak point here: a business that is slowing. The one thing to watch: forward revenue growth trails the market.

03Price Momentum

Is the market behind it right now?

BDMSBangkok Dusit Medical Services Public Company

Total return Current8.9%

Price return Current−12.7%

MOMENTUM RATING↗

AVERAGE36 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-6%4

3-month return-3%6

YTD return+3%5

MID & LONG-TERM▾SCORE

% of 52-week high89%8

1-year return-2%4

3-year return-22%2

5-year return-1%3

MOMENTUM ASSESSMENT

STRENGTHS

None flagged.

WATCH

It's down 2% over the past year, now 11% below its 52-week high. That is a touch ahead of the market.

Returns sit at the market level over the past month (-6%), over three months (-3%) and so far this year (+3%).

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (-22% over three years and -1.2% over five), behind 70% of the market.

BOTTOM LINE

Mixed Momentum

Horizons disagree or sit near the middle of the pack. Momentum investors may want a clearer trend before sizing up. The one thing to watch: the multi-year record is weak.

04Value

Are you paying a fair price for it?

Stop guessing on Bangkok Dusit Medical Services Public Company Limited. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community